Evidence map›Paper›PMID 24368936›Full record

ArticleWorld journal of gastrointestinal endoscopy2013

Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection.

Yuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Koyu Suzuki, Yoshiyuki Fujita

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuto ShimamuraYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Naoki IshiiYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Kaoru NakanoYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Takashi IkeyaYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Kenji NakamuraYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Koichi TakagiYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Katsuyuki FukudaYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Koyu SuzukiYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Yoshiyuki FujitaYuto Shimamura, Naoki Ishii, Kaoru Nakano, Takashi Ikeya, Kenji Nakamura, Koichi Takagi, Katsuyuki Fukuda, Yoshiyuki Fujita, Department of Gastroenterology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
The Nakamura Hajime Eastern Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo clarify the safety and efficacy of repeat endoscopic submucosal dissection (re-ESD) for locally recurrent gastric cancers after ESD.

methodsA retrospective evaluation was performed of the therapeutic efficacy, complications and follow-up results from ESD treatment for early gastric cancers in 521 consecutive patients with 616 lesions at St. Luke`s International Hospital between April 2004 and November 2012. In addition, tumor size, the size of resected specimens and the operation time were compared between re-ESD and initial ESD procedures. A flex knife was used as the primary surgical device and a hook knife was used in cases with severe fibrosis in the submucosal layer. Continuous variables were analyzed using the non-parametric Mann-Whitney U test and are expressed as medians (range). Categorical variables were analyzed using a Fisher's exact test and are reported as proportions. Statistical significance was defined as a P-value less than 0.05.

resultsThe number of cases in the re-ESD group and the initial ESD group were 5 and 611, respectively. The median time interval from the initial ESD to re-ESD was 14 (range, 4-44 mo). En bloc resection with free lateral and vertical margins was successfully performed in all re-ESD cases without any complications. No local or distant recurrence was observed during the median follow-up period of 48 (range, 11-56 mo). Tumor size was not significantly different between the re-ESD group and the initial ESD group (median 22 mm vs 11 mm, P = 0.09), although the size of resected specimens was significantly larger in the re-ESD group (median 47 mm vs 34 mm, P < 0.05). There was a non-significant increase observed in re-ESD operation time compared to initial ESD (median 202 min vs 67 min, respectively, P = 0.06).

conclusionDespite the low patient number and short follow-up, the results suggest that re-ESD is a safe and effective endoscopic treatment for recurrent gastric cancer after ESD.

Indexed as

Endoscopic mucosal resectionEndoscopic submucosal dissectionGastric cancerRecurrent gastric cancerTherapeutic endoscopy

Identifiers

PMID24368936
PMCPMC3870914
OpenAlexW1987005410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.